
Evan Brittain
Associate Program Director, Internal Medicine Residency · Vanderbilt University Medical Center
Credentials: · · ·
History

PresentDepartment of Medicine · Vanderbilt University Medical Center

Until 2013
Until 2012
Until 2011
Until 2009
Research
A Metabolic Basis for Endothelial-to-Mesenchymal Transition
Molecular Cell · 2018 · 245 citations
The Lancet Respiratory Medicine · 2020 · 232 citations
Review · New England Journal of Medicine · 2023 · 229 citations

78 papers

20 papers
- JN
20 papers · 5 as a resident

18 papers
- VA
18 papers · 6 as a fellow
- MF
17 papers

17 papers

16 papers · 5 as a fellow
Grants
- 2022–2027
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
National Heart, Lung, and Blood Institute · R33
Contact PI · $3M · Vanderbilt University Medical Center
- 2022–2027
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Food and Drug Administration · R01
Contact PI · $1.6M · Vanderbilt University Medical Center
- 2026–2027
Carnitine Supplementation in Pulmonary Arterial Hypertension
National Heart, Lung, and Blood Institute · R61
PI · $875K · Vanderbilt University Medical Center
- 2022–2027
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.8M · Vanderbilt University Medical Center
Clinical trials
- 2026–2027
Principal investigator · Recruiting
Vanderbilt University Medical Center
- 2023–2027
Right Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)
Principal investigator · Recruiting
Vanderbilt University Medical Center
- 2023–2027
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
Principal investigator · Recruiting
Vanderbilt University Medical Center
- 2022–2026
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Principal investigator · Recruiting
Vanderbilt University Medical Center
